Cerebral Therapeutics is a clinical-stage pharmaceutical company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy.

Biotechnology

Health Care

Pharmaceutical

Therapeutics

Cerebral Therapeutics, Inc.

Cerebral Therapeutics, Inc.'s headquarters in Aurora, CO, United States

Guy Anthony

Eric D.

Eric Distad

Danielle Hinckley, CPPM, CQE

Julie Foster

Karla Spannbauer

Livnat Halel

Stephen Collins

Mahendra Shah

Matthew Hammond

Timothy Scannell

Weston Nichols

Stephen Farr

The Clinical Development Team at Cerebral Therapeutics is responsible for designing, implementing, and overseeing clinical trials that evaluate the safety and efficacy of innovative therapies for refractory epilepsy. This multidisciplinary team collaborates closely with regulatory bodies, manages project timelines, and ensures compliance with quality standards to advance drug candidates through the clinical pipeline, ultimately aiming to bring transformative treatments to patients in need.

Clinical Development Team

The Leadership Team at Cerebral Therapeutics, Inc. is responsible for setting the strategic direction and vision of the company, overseeing operational efficiency, and ensuring the successful advancement of clinical programs targeting refractory epilepsy. This team collaborates to drive innovation, manage financial planning, and facilitate the development of new treatments, while maintaining a strong commitment to improving patient outcomes in the field of neurology.

Leadership Team

��

Cerebral Therapeutics, Inc.

Org chart

Board & advisors

Teams

Clinical Development Team

Leadership Team

Offices

��������

Cerebral Therapeutics, Inc.

Org chart

Board & advisors

Teams

Clinical Development Team

Leadership Team

Offices

Related companies

��